Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It's Not Too Late to Buy the Stock.

There could be more catalysts for the biotech over the next 18 months.

CryptoAlerta — análise de criptomoedas e mercado em tempo real